Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,441
datasets available to search
ShareScore release 0.9.0
Dataset results
3,441 results for “Immune cells”
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor immune microenvironment and may be more responsive to immune checkpoint blockade
GEO Series GSE275422. Homo sapiens. 24 samples. Type: Expression profiling by array.
Inhibition of p300 impairs Foxp3+ T-regulatory cell function and promotes anti-tumor immunity
GEO Series GSE47989. Mus musculus. 6 samples. Type: Expression profiling by array.
Gut bacteria-derived serotonin promotes immune tolerance in early life through regulation of neonatal gut T cells II
GEO Series GSE248691. Mus musculus. 19 samples. Type: Other.
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
GEO Series GSE224615. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing.
Platelet thromboxane limits T cell immunity to cancer metastasis via ARHGEF1
GEO Series GSE281884. Mus musculus. 15 samples. Type: Expression profiling by high throughput sequencing.
miR-155-5p regulates immune cell recruitment to the fetal lung after choriodecidual Group B Streptococcal infection
GEO Series GSE60628. Macaca nemestrina; synthetic construct. 10 samples. Type: Non-coding RNA profiling by array.
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting a transcriptional memory [HiChIP]
GEO Series GSE211607. Homo sapiens. 3 samples. Type: Other.
Tumour immune contexture is a determinant of anti-CD19 CAR T-cell efficacy in large B cell lymphoma
GEO Series GSE197977. Homo sapiens. 74 samples. Type: Expression profiling by array.
Single-cell gene expression analysis of pulmonary immune cells from BCG-vaccinated and CoMtb mice [scRNAseq]
GEO Series GSE212204. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Piezo2 promotes resistance to radiation by suppressing CD8+ T cell-mediated antitumor immunity via IRF-1/IL-15 signaling
GEO Series GSE236346. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Alzheimer's disease-related presenilins are key to intestinal epithelial cell function and gut immune homeostasis
<p>This archive contains a subset of the transcriptomics data from the IBDome cohort to reproduce the results from the paper:</p> <p>Erkert L, Gamez-Belmonte R, Kabisch M, Schödel L, Patankar JV, Gonzalez-Acera M, Mahapatro M, Bao LL, Plattner C, Kühl AA, Shen J, Serneels L, De Strooper B; TRR241 IBDome Consortium; Neurath MF, Wirtz S, Becker C. <em>Alzheimer's disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis</em>. Gut. 2024 Sep 9;73(10):1618-1631. doi: 10.1136/gutjnl-2023-331622. PMID: 38684238</p>
Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer by Multiplexed Tissue Imaging
Open the record for dataset details and reuse information.
raw data related to project "Circulating biomarkers as predictors of gender-specific response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients"
<p><strong>Sex-related differences in serum biomarker levels predict the activity and efficacy of Immune Checkpoint Inhibitors in advanced melanoma and Non-Small Cell Lung Cancer patients.</strong></p> <p><strong>Abstract </strong></p> <p><strong>Background:</strong> Immune Checkpoint Inhibitors (ICIs) lead to durable response and a significant increase in long-term survival in patients with advanced malignant melanoma (MM) and Non-Small Cell Lung Cancer (NSCLC). The identification of serum cytokines that can predict their activity and efficacy, and their sex interaction, could improve treatment personalization. </p> <p><strong>Methods: </strong>In this prospective study, we enrolled immunotherapy-naïve patients affected by advanced MM and NSCLC treated with ICIs. The primary endpoint was to dissect the potential sex correlations between serum cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, GM-CSF, MCP-1, TNF-ɑ, IP-10, VEGF, sPD-L1) and the overall response rate (ORR). Secondly, we analyzed biomarker changes during treatment related to ORR, disease control rate (DCR), progression free survival (PFS) and overall survival (OS). Blood samples, collected at baseline and during treatment until disease progression (PD) or up to 2 years, were analyzed using Luminex xMAP or ELLA based technology. </p> <p>Three Luminex xMAP assays and two ELLA microfluidic cartridges were used to screen 28 immune-related biomarkers in 38 paired serum and citrate-theophylline-adenosine-dipyridamole (CTAD) plasma samples collected from 10 advanced melanoma or non-small cell lung cancer (NSCLC) patients at different time points during immunotherapy.</p> <p><strong>Results</strong>: Serum samples from 161 patients (98 males/63 females; 92 MM/69 NSCLC) were analyzed for treatment response. At baseline, IL-6 was significantly lower in females (F) <em>versus</em> males (M); lower levels of IL-4 in F and of IL-6 in both sexes significantly correlated with a better ORR, while higher IL-4 and TNF-ɑ values were predictive of a lower probability of ORR in F <em>versus</em> M. One hundred and sixty-five patients were evaluable for survival analysis: at multiple Cox regression, an increased risk of PD was observed in F with higher baseline values of IL-4, sPD-L1 and IL-10, while higher IL-6 was a negative predictor in males. In males, higher levels of GM-CSF predict a longer survival, whereas higher IL-1β predicts a shorter survival. Regardless of sex, high baseline IL-8 values were associated with an increased risk of both PD and death, and high IL-6 levels only with shorter OS. </p> <p>Twenty-three of 28 biomarkers were detected both in serum and plasma by at least one of the assays, including IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, GM-CSF, IFN-γ, TNF-α, VEGF, IP-10, MCP-1, eotaxin, fractalkine, G-CSF, IFN-α, IL-1RA, IL-13, IL-17A, MIP-1β and sPD-L1. Conversely, FGF-2 and IL-1α were not detected in both matrices; GRO-α factor and EGF were detected only in serum and MIP-1α only in plasma. sPD-L1, MCP-1, IFN-γ, IL-8, MIP-1β and VEGF were, respectively, 1.15-, 1.44-, 1.83-, 2.43-, 2.82-, 6.72-fold higher in serum, whereas IL-10, IL-4, IL-2 and IL-5 were 1.05-, 1.19-, 1.92- and 2.17-fold higher, respectively, in plasma. IP-10 levels were higher in plasma but, as well as for VEGF, the bias serum versus plasma varied depending on the assay used (IP-10: −5.7% to −145%; VEGF: 115% to 165%). No significant differences were found for the remaining nine analyzed cytokines.</p> <p><strong>Conclusions</strong></p> <p>Serum IL-1β, IL-4, IL-6, IL-10, GM-CSF, TNFɑ, and sPDL1 had a significant independent sex-related predictive impact on ORR, PFS and OS in melanoma and NSCLC patients treated with ICIs. These results will potentially pave the way for new ICI combinations, designed according to baseline and early changes of these cytokines and stratified by sex. </p> <p>The cytokine and sPD-L1 levels may differ between serum and plasma samples collected from cancer patients treated with immunotherapy, and the results obtained can be influenced by the different characteristics of the tested assays.</p>
Epigenetic programming by H3K23ac defines lineage fate of Meg3+ hematopoietic stem cells and drives immune aging (Supplemental Table)
Open the record for dataset details and reuse information.
Mapping spatial organization and genetic cell state regulators to target immune evasion in ovarian cancer
<p>This collection of data accompanies the study: <a href="https://www.nature.com/articles/s41590-024-01943-5">Yeh, Aguirre, Laveroni <em>et al.</em> <strong>Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer. </strong>(2024). </a><em><strong><a href="https://www.nature.com/articles/s41590-024-01943-5">Nature Immunology</a>.</strong></em> Files are provided in the form of RObjects (extension .rds) or tabulated data (extension .csv) to reproduce the results and figures provided in the paper via the the R programming environment using Code provided <a href="https://github.com/Jerby-Lab/HGSC_SpatialPerturbational">here</a>. </p> <p> </p> <p>Data collected and processed and published as a part of this study of tubo-ovarian high grade serous carcinoma (HGSC) includes: </p> <ul> <li>~<strong>2.5 million single cell spatial transcriptomics profiles</strong> from <strong>130 HGSC tumors</strong> of <strong>94 patients</strong></li> <li>Matching de-identified <strong>clinical annotations</strong> and clinical outcomes.</li> <li>Matching <strong>targeted genomic data</strong> from the bulk tumor tissues.</li> <li><strong>Perturb-seq CRISPR knockout</strong> data in ovarian cancer cells in monoculture and co-culture with Natural Killer (NK) cells.</li> </ul> <p>The spatial transcriptomics, Perturb-Seq, and matched H&E (Hematoxylin & Eosin, where available) are also provided via the Single Cell Portal with an <strong>interactive interface</strong> (<a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2640/hgsc-spatial-cohort-discovery-dataset">SCP2640</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2641/hgsc-spatial-cohort-validation-1-dataset">SCP2641</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2650/hgsc-spatial-cohort-validation-2-dataset">SCP2650</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2644/hgsc-spatial-cohort-test-1-dataset">SCP2644</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2646/hgsc-spatial-cohort-test-2-dataset">SCP2646</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2707/hgsc-spatial-study-perturb-seq">SCP2707</a>).</p> <p>The collection also includes previously published data that was analyzed and used in this study to examine the generalizability of the findings, evaluate immunotherapy predictors, and for data-driven experimental design.</p> <p>The SeuratObj.zip contains six SeuratObjects matching the five spatial transcriptomcs datasets (Discovery, Validation 1, Validation 2, Test 1 and Test 2) and Perturb-Seq data.</p> <p>The Yeh2024.zip file includes the study's data and additional datasets/results to reproduce the study's figures. A detailed description of the files included in the repository is provided in `README.txt` and `README.xlsx`</p>
Microglia from patients with multiple sclerosis display cell-autonomous immune activation state
<p>This repository contains the data and the code used in tanja hyvarinen's project (tanja.hyvarinen@tuni.fi)</p> <p>"analysis" contains the processing and analysis of the bulk RNA sequencing data, contains the analysis of the integration between our RNA seq and external datasets.<br>"fastq" contains the raw fastq sequences of the bulk RNA sequencing<br>"counts" contains the results of processing the fasta sequences with nfcore rnaseq workflow </p> <p>Analysis and integration folders can contain the starting raw data in "data", the R scripts in order of execution (op1, op2 ..) and the "output" folder that contains the final processed data of each operation.</p>
Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients
ClinicalTrials.gov study NCT06897436. IPD Sharing: NO. Countries: 0. Publications: 0.
Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies
ClinicalTrials.gov study NCT05612607. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors
ClinicalTrials.gov study NCT03472352. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
ClinicalTrials.gov study NCT00724672. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.